Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shares hike for Orthofix after positive quarter

This article was originally published in Clinica

Executive Summary

Revenue growth of 6% helped Orthofix International record its highest share price in more than a year. The McKinney, Texas-based company saw shares reach $30.47 during trading on July 31, the company’s best pricing since June 2008. Revenues for the period were $137.5m, helped by a 13% growth in revenue from Orthofix’s spinal products business, to $70.7m. The firm’s CEO Alan Milinazzo attributed the good performance from the spine business to the recent launches of the Firebird pedicle screw system, the Pillar SA interbody device and the Trinity Evolution stem cell-based allograft. The company’s bottom line improved slightly from $5.8m to $5.9m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel